Product Details

Hexaxim Vaccine**

Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) & haemophilus influenzae type B conjugate vaccine (adsorbed)
0.5 mL
Suspension for injection

ROA

Intramuscular

Applicant Name

Sanofi-Aventis Nigeria Limited

NRN

A6-0447

Status

Active


Composition

Each dose (0.5 mL) contains: Diphtheria Toxoid not less than 20 IU (30 Lf), Tetanus Toxoid not less than 40 IU (10 Lf), Bordetella pertussis antigens (Pertussis Toxoid 25 micrograms, Filamentous Haemagglutinin 25 micrograms), Poliovirus (Inactivated) (Type 1 (Mahoney) 40 D-antigen units, Type 2 (MEF-1) 8 D-antigen units, Type 3 (Saukett) 32 D-antigen units), Hepatitis B surface antigen 10 micrograms, Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein 22-36 micrograms. The vaccine may contain traces of glutaraldehyde, formaldehyde, neomycin, streptomycin and polymyxin B which are used during the manufacturing process. Excipient with known effect: Phenylalanine 85 micrograms  

ATC Code

 

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

0.5 mL x 1's (in Prefilled syringe)  

Product Description

Suspension for injection in pre-filled syringe. Hexaxim is a whitish, cloudy suspension

Manufacturer Name

Sanofi Pasteur S.A.

Manufacturer Country

FRANCE  

Approval Date

2023-02-23  

Expiry Date

2028-02-22